10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001651308-22-000139`
Period End Date	20220630
Filing Date	20220808
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	bgne-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 80 Cash Flow Statement 85 Stockholders Equity 34 Comprehensive Income 20

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.53B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.78B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$328.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.35B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$310.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.33B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$333.00K	USD	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$2.24B	USD	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$1.17B	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.35B	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$483.11M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$172.26M	USD	Point-in-time
Inventories	`InventoryNet`	$262.21M	USD	Point-in-time
Inventories	`InventoryNet`	$242.63M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$207.38M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$270.17M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.35B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.61B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.94M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$9.93M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.88M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$633.10M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$587.61M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$117.58M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$117.43M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$43.33M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$46.68M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$103.43M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$110.42M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$130.96M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$163.05M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.03B	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.03B	USD	Point-in-time
Total assets	`Assets`	$8.65B	USD	Point-in-time
Total assets	`Assets`	$7.38B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$262.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$234.35M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$558.05M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$454.18M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$187.41M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$163.40M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$15.56M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$21.39M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$21.93M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$24.79M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$120.80M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$125.39M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$380.73M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.72B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$427.56M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.55B	CNY	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.40B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$202.11M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$185.21M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.24B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.29B	CNY	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$220.29M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$167.57M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$41.92M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$43.04M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$14.17M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$14.74M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$269.56M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$219.38M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$54.23M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$48.43M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$803.41M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$677.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.40B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.08B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,349,639,439 and 1,334,804,281 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$133.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,349,639,439 and 1,334,804,281 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$134.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.19B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.36B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$17.95M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-82.45M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.97B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.97B	USD	Point-in-time
Total equity	`StockholdersEquity`	$6.24B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.30B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.65B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$7.38B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$648.20M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$149.99M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$341.57M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$755.86M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$136.41M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$36.26M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$68.95M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$71.17M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$378.21M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$768.12M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$676.82M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$356.09M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$625.98M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$331.40M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$232.29M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$414.39M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$376.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$187.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$375.00K	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$1.16B	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$624.83M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.53B	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$780.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-404.67M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-439.40M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-474.84M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-882.69M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-9.04M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$21.50M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-4.87M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$11.43M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-117.65M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-867.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-4.99M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-129.62M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-418.71M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-480.57M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-978.83M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-557.59M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-230.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$26.89M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-4.86M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$13.86M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.01B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-480.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-413.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-571.45M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.75	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.43	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.40	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.43	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.35	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.40	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.75	USD	2 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.34B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.19B	shares	2 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.19B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.33B	shares	2 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.19B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.34B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.19B	shares	2 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	2 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-4.52	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-9.80	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-5.56	USD	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-5.23	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-4.52	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-9.80	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-5.56	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-5.23	USD	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.63M	shares	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	91.85M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.80M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	91.66M	shares	2 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.63M	shares	2 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.80M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	91.66M	shares	2 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	91.85M	shares	1 Quarter

Cash Flow Statement 85 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.01B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-480.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-413.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-571.45M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$32.06M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$21.16M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$146.86M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$110.62M	USD	2 Qtrs
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-23.53M	USD	2 Qtrs
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-6.03M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$53.50M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	2 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-45.58M	USD	2 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-53.90M	USD	2 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-12.31M	USD	2 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$7.55M	USD	2 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$11.21M	USD	2 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$6.36M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.34M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-307.43M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$28.29M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$31.63M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$77.20M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-32.31M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-30.36M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-42.56M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.69M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$19.52M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-76.74M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$138.88M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.19M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-2.11M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-295.17M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-616.52M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$80.92M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$95.42M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$1.36B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$11.50M	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.05B	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.00B	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$75.00M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$8.50M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$7.50M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$543.54M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$869.10M	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$10.82M	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	-	USD	2 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$67.59M	USD	2 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$112.59M	USD	2 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$115.41M	USD	2 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$15.96M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$18.97M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$35.60M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$143.05M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-28.85M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.26M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-71.21M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$152.52M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$396.68M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.79B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.54B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.79B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.54B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.53B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.78B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$328.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$310.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$333.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.94M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$9.93M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.88M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$24.44M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$14.53M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$12.90M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$14.27M	USD	2 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$28.89M	USD	2 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$58.68M	USD	2 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	$45.00M	USD	2 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	-	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.24B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.61B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.89B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.00B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.30B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.35B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Cost from issuance of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$152.00K	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$25.75M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$7.09M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$11.88M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$9.85M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$65.56M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$81.31M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.83M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$64.79M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-100.40M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-99.90M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-496.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$8.89M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.74M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-434.27M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-571.45M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$66.50M	USD	1 Quarter
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.24B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.61B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.89B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.00B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.30B	USD	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.35B	shares	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.01B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-480.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-413.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-571.45M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$5.86M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-88.08M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-97.46M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$9.63M	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	2 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-361.00K	USD	2 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$136.00K	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-12.31M	USD	2 Qtrs
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.07M	USD	2 Qtrs
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-2.44M	USD	1 Quarter
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-599.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-671.35M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.11B	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-471.45M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-408.69M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.